Ruti Aga's Six-Year Ban: The 2+4 Arithmetic, the Glucocorticoid Mislabelling, and the Prescription That Ended a Career

Six years. In athletics, that number usually points at an anabolic steroid case. In Ruti Aga's case it did not. It came from methylprednisolone — a glucocorticoid listed under class S9 of the WADA Prohibited List, not class S1. This is not a vocabulary quibble; it is the legal hinge of the entire matter. S9 glucocorticoids are prohibited in-competition only — by injection, oral or rectal routes. A therapeutic knee injection given out of competition is fully legal. It becomes a violation only when residues are present in a sample collected on race day.

The report this story is built on calls methylprednisolone a prohibited steroid and states that WADA classifies it as performance enhancing. Both claims are incomplete. The gap matters, because a reader who files this as an anabolic-steroid case will never see that a legitimate defence existed here.

The first split looked clean; the third told a different story.

The context is spare. Ruti Aga, 32, Ethiopian marathoner. In March she won a half marathon in China. Her in-competition sample came back positive. The Athletics Integrity Unit issued its decision on Thursday. Aga had been provisionally suspended since 10 September, and the six-year ban is backdated to that same date. The source gives no race name, no year, no mark.

Her record is separate: the 2026 Tokyo Marathon title and three runner-up finishes at World Marathon Majors. Public records place her Berlin 2026 second place near 2:18:34 and Tokyo 2026 near 2:20:40 — figures that were absent from the original report and should be treated as pending verification. No form conclusion can be drawn from a mark the source does not carry.

Now the arithmetic. Two years for the presence violation, four for tampering — six in total. The two-year base tells us the panel treated the substance as specified and found no proven intent to cheat. The four-year block is the Code's standard tampering sanction. That sum reveals something specific: the panel rejected the no-significant-fault mitigation that would otherwise have pulled the presence sanction below two years. And the 10 September backdating is not a discount; provisional suspension time counts against the ban regardless.

Where did the tampering charge originate? The defence claimed a knee injury, treated with this medication. The problem was the prescription submitted to support it. It was written by a family member with no medical registration, who claimed to have used an old prescription pad from a former workplace. The clinic named on the pad did not exist, and the clinic itself disowned any connection to it. Three independent verification checks, all three failed.

The sanction did not come from the drug; it came from the paperwork.

This is where the case separates from ordinary doping matters. A knee injury and its treatment are mechanistically credible. Chronic knee pathology is routine in high-volume marathoners, and intra-articular methylprednisolone is standard sports-medicine practice. That very credibility is why the forgery becomes decisive. Had the treatment been real, it could have been defended with actual records, or covered by a Therapeutic Use Exemption. Neither happened.

When I logged 400m splits by hand in Guntur in 2026, I learned a basic rule: in any dataset, check the timestamps first, because time is the one thing you cannot splice in afterwards. The AIU applied exactly that discipline. The prescription date, the clinic's registration and the doctor's identity stopped agreeing with each other.

The part that gets left out of headlines: the Chinese label-race circuit is a scheduled, low-risk income tier for East African marathoners. Between Majors, these races pay appearance fees. That same circuit is now the AIU's highest-yield testing ground. The appearance-fee economy and the testing economy are colliding inside the same races.

There is a structural issue underneath. Aga appears to have had no credentialed team physician. That is not a filing error; it is the signature of an athlete operating outside formal medical structures. An injured marathoner carries pressure to protect appearance income, glucocorticoids are the cheapest available tool for masking pain, and the surrounding medical network is informal. The forged prescription is a symptom of that system, not its cause.

The contrarian read: the substance that produced a six-year ban has no proven endurance benefit. Glucocorticoids reduce pain and inflammation; they do not directly improve running economy. The severity came from the concealment, not the pharmacology. As policy that is defensible. As optics it will be cited as disproportionately harsh enforcement against African road runners — and that argument will be fought on perception, not on the facts of this file.

The disqualification scope deserves clarity too. The violation is anchored to a later March race, so the 2026 Tokyo title and the three Major runner-up finishes are not automatically annulled. But the March result, its prize money and any World Ranking points accrued afterwards should be void under standard AIU practice — a scope the report never states.

What comes next? The CAS appeal window typically runs about 21 days, but a document-based finding is extremely hard to overturn. A six-year ban at 32 pushes any return to roughly 38, and Ethiopia's women's marathon depth offers no lane for a 38-year-old returnee — least of all one with a doping record. In practical terms, this is a lifetime ban. If the prescription was forged, a criminal dimension for document falsification also exists, outside AIU jurisdiction and potentially referable to national authorities.

The real question is not whether Ruti Aga doped. It is what options remain for the next 32-year-old in an Ethiopian training cluster with a bad knee, no team doctor and an appearance fee on the line. The AIU has built a remarkably efficient document-verification machine. The sport has not yet built the medical infrastructure that would make the machine unnecessary.